News | Radiation Oncology | April 01, 2020

ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care

Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform

Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform

April 1, 2020 — ViewRay, Inc. announced a strategic collaboration with VieCure, an artificial intelligence (AI) informatics company with a leading point-of-care clinical decision support platform and a comprehensive electronic medical record (EMR) in oncology. The collaboration is designed to drive personalized care and treatment to patients by educating oncology practices on both companies' precision oncology solutions.

Through the alliance, clinicians will have access to ViewRay's MRIdian magnetic resonance imaging (MRI)-guided radiation therapy system and VieCure's VCurePrecision EMR platform. VCurePrecision provides a real-time decision-support system that combines clinical knowledge with patient data to assist oncologists in generating personalized treatment plans and managing a patient's care throughout his or her cancer therapy. ViewRay's MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue and tumors while radiation is delivered. MRIdian also offers a powerful gating feature that automatically controls the radiation beam throughout each treatment, turning it off if the tumor moves outside of the targeted treatment area. The combination of MRIdian and VCurePrecision offers a formidable comprehensive precision oncology solution. 

"Through our collaboration with VieCure, we gain access to a wider network of oncologists and healthcare systems to offer a comprehensive cancer treatment and records integration solution," said Paul Ziegler, senior vice president of sales and marketing at ViewRay. "Both VieCure and ViewRay are leaders within their field – bringing clinicians a state-of-the-art AI-powered patient data system and the world's first MRI-guided radiation therapy system. The ability to deliver these world-class solutions together is a real benefit to oncology practices interested in advancing personalized treatment to improve patient outcomes."

"Oncologists are embracing the paradigm shift toward data-driven precision medicine, but they face a myriad of clinical workflow and content-related challenges," said Fred Ashbury, Ph.D., chief scientific officer at VieCure. "Our platform combines patient data with leading scientific knowledge in radiation oncology, systemic therapy and surgical oncology, and generates individualized treatment prescriptions throughout the patient's diagnosis and care journey. We are excited to deliver even better insights to the multidisciplinary clinical team and the participating radiation oncologists, medical physicists, therapists and treatment planners who will use our A.I. enabled smart EMR."

VieCure's oncology-specific and AI-enabled VCurePrecision platform is aimed at both private practice cancer centers and large provider organizations as a point-of-care solution to collect, curate, streamline and manage diagnostic and treatment options ranging from molecular test results through patient-reported outcomes. The platform also incorporates AI clinical rules to personalize standard of care to the specific characteristics of an individual's cancer.

Currently 34 MRIdian systems are installed at hospitals around the world, where they are being used to treat a wide variety of solid tumors and are the focus of numerous ongoing research initiatives. MRIdian has been the subject of hundreds of peer-reviewed publications, scientific meeting abstracts and presentations. More than 8,000 patients have been treated with MRIdian. For a list of treatment centers, see: https://viewray.com/mridian-locator.

Related Content

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

News | Radiation Oncology | July 28, 2021
July 28, 2021 — IntraOp Medical Corporation announced that ...
Researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London have automated brain MRI image labeling, needed to teach machine learning image recognition models, by deriving important labels from radiology reports and accurately assigning them to the corresponding MRI examinations

Getty Images

News | Magnetic Resonance Imaging (MRI) | July 28, 2021
July 28, 2021 — Researchers from the School of Biomedical Engineering & Imaging Sciences at...
Recommendations address when and how radiation therapy should be used and outline best practices for patient-centered care

Figure 1. The guideline also includes treatment algorithms for initial local management (Figure 1) and local management following an unplanned excision (Figure 2).

News | Radiation Therapy | July 27, 2021
July 27, 2021 — A ...
Radiation oncologists urged Congress to reverse proposed CMS cuts and create more equity in access to cancer treatments

Getty Images

News | Radiation Oncology | July 26, 2021
July 26, 2021 — A record number of radiation oncologists met with Congressional leaders and staff last week as part o
Videos | Artificial Intelligence | July 22, 2021
This is an overview of trends and technologies in radiology...
64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses

64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses. Coronal T2-weighted single shot fast spin echo and coronal T1-weighted fat-saturated spoiled gradient echo acquired during corticomedullary phase—ccLS5 lesion outlined red for clarity.

News | Magnetic Resonance Imaging (MRI) | July 22, 2021
The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
An example of Viz.AI's pulmonary embolism AI application and mobile alert to the physician on-call. Viz.AI and Avicenna.AI Partner to Launch Artificial Intelligence Care Coordination for Pulmonary Embolism and Aortic Disease

An example of Viz.AI's pulmonary embolism AI application and mobile alert to the physician on-call. 

News | July 21, 2021
July 21, 2021 — Artificial int...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...